| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |